Vanguard Group Inc Elanco Animal Health Inc Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Vanguard Group Inc holds 49,258,240 shares of ELAN stock, worth $898 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
49,258,240
Previous 49,468,637
0.43%
Holding current value
$898 Million
Previous $737 Million
8.8%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding ELAN
# of Institutions
407Shares Held
473MCall Options Held
2.6MPut Options Held
916K-
Dodge & Cox San Francisco, CA83.8MShares$1.53 Billion0.84% of portfolio
-
Primecap Management CO Pasadena, CA52.9MShares$964 Million0.65% of portfolio
-
Black Rock Inc. New York, NY26.6MShares$486 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD22.1MShares$404 Million0.04% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.2MShares$368 Million9.96% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $8.64B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...